The Injectable Diabetes Drug Byetta May Cause
Pancreatitis that May Lead to Pancreatic Cancer: Persons Taking Byetta
Should Be Aware of Pancreatic Cancer Danger and Consult
Their Physician Regarding Potential Pancreas Cancer Risks by Texas Byetta Pancreatic
Cancer Lawyer, Byetta Pancreatitis Lawyer and Byetta
Pancreas Cancer Lawyer Jason S. Coomer
In November 2009, the FDA revised the prescribing
information for Byetta
to include information on reported cases of acute pancreatitis
in patients using this drug. This revision came after the FDA had received more than 30 reports of
acute pancreatitis in Byetta users. Based on these adverse reports, the FDA directed Amylin to conduct six
post-marketing studies regarding acute pancreatitis
associated with the use of Byetta, as well as to look at the
risk of Byetta cancer, including thyroid cancer and
pancreatic cancer.
Pancreatic Cancer, Exocrine Pancreas Cancers (Pancreatic
Adenocarcinoma) and Endocrine Pancreatic Cancers
Pancreatic cancer is the fourth leading
cause of cancer death for both men and women and is one of
the most deadly of all types of cancer. This year
approximately 45,000 Americans will be diagnosed with
pancreatic cancer and about 38,000 will probably die from it.
The most common kind of pancreatic cancer
is pancreatic adenocarcinoma and includes about 90% of the
cases of pancreatic cancer. Pancreatic adenocarcinoma
is a cancerous overgrowth of exocrine pancreatic cells and
is unfortunately commonly undetected until it is too late
for the patient. Pancreatic adenocarcinoma because of
late detection can often result a fatal diagnosis with very
limited survival time. Other forms of exocrine pancreas
cancer include: intraductal papillary mucinous neoplasm
(IPMN), adenosquamous carcinomas, acinar cell carcinomas,
mucinous cystadenocarcinomas, signet ring cell carcinomas,
hepatoid carcinomas, colloid carcinomas, undifferentiated
carcinomas, pancreatoblastomas, and undifferentiated
carcinomas with osteoclast-like giant cells.
Unfortunately, pancreatic cancer is
difficult to diagnose, and the diagnosis is often made late
in the course of the disease. Early detection of
pancreatic cancer is essential and will greatly improve a
person's chances of surviving the disease. As such, people
that have taken Byetta, especially those with symptoms of
weight loss, dark urine and clay-colored stools, back pain,
and jaundice, should seek advice from a qualified medical
professional as to if they may have pancreatic cancer and
what symptoms they should be aware of to detect any early
onset of pancreatic cancer.
Acute Pancreatitis, Hemorrhagic
Pancreatitis, Necrotizing Pancreatitis
Acute pancreatitis is a sudden inflammation of the pancreas
that occurs over a short period of time. The pancreas is a
digestive organ behind the stomach that secretes essential
enzymes needed for the digestion of certain foods, including
fats, carbohydrates and proteins. During an episode of acute
hemorrhagic pancreatitis, several symptoms relating to digestion
and abdomen may occur. In severe cases, the person may
experience confusion, difficulty breathing, or respiratory
failure. The person may also fall into a coma.
The severity of acute
pancreatitis may range from mild abdominal discomfort to a
severe, life-threatening illness. However, the majority of
people with acute pancreatitis (more than 80%) recover
completely after receiving the appropriate treatment. In
very severe cases, acute pancreatitis can result in bleeding
into the gland, serious tissue damage, infection, and cyst
formation. Severe pancreatitis can also create conditions which
can harm other vital organs such as the heart, lungs, and
kidneys.
The warning signs of pancreatitis include: 1) Upper abdominal
pain that radiates into the back. Patients may describe this as
a "boring sensation" that may be aggravated by eating,
especially foods high in fat. 2) Swollen and tender abdomen 3)
Nausea and vomiting 4) Fever and 5) Increased heart rate.
Acute hemorrhagic pancreatitis is the sudden
inflammation of the pancreas. This leads to death of pancreatic
tissue and the formation of lesions, causing extensive bleeding.
Necrotizing pancreatitis is a serious health condition where
a person's pancreas is inflamed and bleeding. In Necrotizing
Pancreatitis patients, there is inflammation and tissue death,
with the pancreas destroying itself. Whereas in
Hemorrhagic Pancreatitis patients, the pancreas is bleeding.
Both are serious conditions and should be treated immediately.
Byetta Pancreatic Cancer Lawsuit Information, Byetta
Pancreas
Cancer Lawsuit Information, and Byetta Cancer Death Lawsuit
Information
Byetta
Pancreas
Cancer Lawsuits and Byetta Pancreatic Cancer Lawsuits are in
the process of being reviewed and filed as recent scientific
evidence
indicates that the injectable diabetes drug, Byetta (Exenatide),
may cause an
increased risk of pancreatitis, this side effect can and
often does lead to the development of pancreatic cancer.
Pancreatic Cancer is an extremely deadly form of cancer. Most
people diagnosed with Pancreatic Cancer or Cancer of the
Pancreas do not survive
beyond the five years and many are given much less time as
Pancreatic Cancer is hard to detect. Early detection
is the key to surviving pancreatic cancer.
Diabetics are more vulnerable to developing
pancreatitis than those without the disease, recent studies
indicate that taking Byetta can potentially increase the risk
of pancreatitis. And,
if pancreatitis becomes chronic, the inflammation of the
pancreas will alter its normal structure and functions.
This can lead to pancreatic cancer.
For more information on this topic, please feel free to go to the following web page: Byetta Pancreatic Cancer Lawsuit, Byetta Pancreas Cancer Lawsuit, and Byetta Cancer Death Lawsuit Information.
To find out more about Pigmentation Treatments Delhi
ReplyDelete